Skip to content

Clinical trials

Pathologic Processes trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pathologic Processes Country / region: Canada Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20092
20101
20111
20122
20131
20141
20152
20173
20191
20202
20232
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting4
Active, not recruiting2
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vertex Pharmaceuticals Incorporated3
University of Washington, the Collaborative Health Studies Coordinating Center2
AstraZeneca1
AusperBio Therapeutics Inc.1
British Columbia Cancer Agency1
Celgene1
Coloplast A/S1
Eli Lilly and Company1
KAI Pharmaceuticals1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pathologic Processes24
Lung Diseases11
Respiratory Tract Diseases11
Digestive System Diseases6
Cystic Fibrosis5
Genetic Diseases, Inborn5
Inflammation5
Pancreatic Diseases5
Fibrosis4
Infant, Newborn, Diseases3

Trials

Showing 76 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.